Pfizer's COVID Pill
Protects Against Omicron Variant, New Study Finds.
The results of the study of the effectiveness of Pfizer's Paxlovid pill were released on Dec. 14.
We are confident that, if..
Credit: Wibbitz Top Stories Duration: 01:30Published
On Tuesday, Pfizer Inc said the final analysis of its antiviral COVID-19 pill still showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and recent lab data..